1. Home
  2. TNET vs ADMA Comparison

TNET vs ADMA Comparison

Compare TNET & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

HOLD

Current Price

$37.87

Market Cap

1.7B

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$8.07

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNET
ADMA
Founded
1988
2004
Country
United States
United States
Employees
2700
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
3.6B
IPO Year
2000
2012

Fundamental Metrics

Financial Performance
Metric
TNET
ADMA
Price
$37.87
$8.07
Analyst Decision
Hold
Buy
Analyst Count
5
2
Target Price
$65.80
$32.00
AVG Volume (30 Days)
437.1K
7.4M
Earning Date
04-24-2026
05-06-2026
Dividend Yield
2.92%
N/A
EPS Growth
N/A
N/A
EPS
3.20
0.60
Revenue
$5,010,000,000.00
$42,219,783.00
Revenue This Year
N/A
$27.46
Revenue Next Year
$3.30
$22.11
P/E Ratio
$11.56
$13.82
Revenue Growth
N/A
43.85
52 Week Low
$33.67
$7.21
52 Week High
$88.56
$25.67

Technical Indicators

Market Signals
Indicator
TNET
ADMA
Relative Strength Index (RSI) 42.84 16.06
Support Level $34.44 N/A
Resistance Level $39.10 $16.44
Average True Range (ATR) 1.65 1.09
MACD 0.78 -0.72
Stochastic Oscillator 62.14 7.90

Price Performance

Historical Comparison
TNET
ADMA

About TNET TriNet Group Inc.

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: